Kenvue Inc. (KVUE)
23.38
0.07 (0.30%)
At close: Mar 24, 2025, 3:59 PM
0.30% (1D)
| Bid | 23.08 |
| Market Cap | 44.68B |
| Revenue (ttm) | 15.42B |
| Net Income (ttm) | 1.03B |
| EPS (ttm) | 0.54 |
| PE Ratio (ttm) | 43.29 |
| Forward PE | 17.7 |
| Analyst | Hold |
| Ask | 23.37 |
| Volume | 10,306,242 |
| Avg. Volume (20D) | 16,467,345.9 |
| Open | 23.15 |
| Previous Close | 23.31 |
| Day's Range | 23.09 - 23.59 |
| 52-Week Range | 17.67 - 24.46 |
| Beta | 1.21 |
About KVUE
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the ...
Industry Household & Personal Products
Sector Consumer Defensive
IPO Date May 4, 2023
Employees 22,000
Stock Exchange NYSE
Ticker Symbol KVUE
Website https://www.kenvue.com
Analyst Forecast
According to 14 analyst ratings, the average rating for KVUE stock is "Hold." The 12-month stock price forecast is $24, which is an increase of 2.67% from the latest price.
Stock ForecastsNext Earnings Release
Kenvue Inc. is scheduled to release its earnings on May 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-4.53%
Kenvue shares are trading lower after the company ...
Unlock content with
Pro Subscription
1 month ago
+3.18%
Shares of consumer staples stocks are trading higher. The sector may be rising amid a rotation out of tech stocks and into risk-off stocks amid AI competition fears from China.
